|Articles|December 13, 2022
Supplements and Featured Publications
- Role of the Bruton Tyrosine Kinase Pathway in Multiple Sclerosis
- Volume 28
- Issue 16
Participating Faculty: Role of the Bruton Tyrosine Kinase Pathway in Multiple Sclerosis
Author(s)Kavita V. Nair, PhD
Advertisement
Faculty
Kavita V. Nair, PhD
Professor of Neurology and Pharmacy
Department of Neurology
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Faculty Disclosures
This faculty member has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Kavita V. Nair, PhD
CONSULTANCIES OR PAID ADVISORY BOARDS
Genentech, Novartis, PhRMA Foundation, TG Therapeutics, Inc
GRANTS PENDING
Bristol Myers Squibb
GRANTS RECEIVED
Bristol Myers Squibb, Genentech, Novartis
HONORARIA
PTCD Education
MEETING/CONFERENCE ATTENDANCE
American Academy of Neurology
Articles in this issue
over 3 years ago
Role of the Bruton Tyrosine Kinase Pathway in Multiple SclerosisAdvertisement
Advertisement
Advertisement
Trending on AJMC
1
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
2
Real-World Data Show MASH Progresses Faster Than Trials Suggest
3
Sarcoma's Rarity Limits Trials and Biomarker-Driven Treatment Options: Alexander Spira, MD, PhD, FACP, FASCO
4
Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo
5
